| 000 | 00741nam a22002297a 4500 | ||
|---|---|---|---|
| 008 | 110817t xxu||||| |||| 00| 0 eng d | ||
| 040 | _cVAD | ||
| 041 | _aEngels | ||
| 110 | _aNational Institute for Health and Clinical Excellence | ||
| 245 | _aMethadone and buprenorphine for the management of opioid dependence [PDF] | ||
| 260 |
_aLondon _bNHS _c2010 |
||
| 300 | _a37 p. | ||
| 490 |
_aNICE technology appraisal guidance _v114 |
||
| 650 | _adrugs | ||
| 650 | _aheroïne | ||
| 650 | _ahulpverlening | ||
| 650 | _amethadon | ||
| 650 | _abuprenorfine | ||
| 650 | _abehandelrichtlijnen | ||
| 650 | _aVerenigd Koninkrijk | ||
| 856 | _uhttp://www.google.com/search?q=methadone-and-buprenorphine-for-the-management-of-opioid-dependence | ||
| 999 |
_c15582 _d15582 |
||